期刊文献+

HGF经HGF/Akt通路抑制肝癌细胞HCCC-9810的增殖 被引量:1

HGF inhibited the proliferation of liver carcinoma cell line HCCC-9810 via HGF / Akt signaling pathway
下载PDF
导出
摘要 目的:观察肝细胞生长因子(HGF)对人胆管细胞型肝癌细胞HCCC-9810增殖的影响,并探讨其分子机制。方法 :HGF处理HCCC-9810细胞后,用MTT及EdU法检测癌细胞的增殖;siRNA干扰技术抑制HCCC-9810细胞内源性Akt的表达,Western blot检测癌细胞Cyclin D1蛋白表达和Akt磷酸化的变化。结果:50和100 ng/ml HGF显著抑制肝癌细胞HCCC-9810的增殖。Western blot结果显示,HGF处理后的肝癌细胞Akt磷酸化和Cyclin D1表达量明显下调。siRNA干扰Akt的表达,阻断了HGF诱导的Cyclin D1表达量的下调及细胞增殖抑制。结论:HGF通过下调Akt磷酸化和Cyclin D1表达量抑制肝癌细胞HCCC-9810的增殖。 Objective:To identify the novel function of hepatocyte growth factor(HGF) in liver carcinoma cell HCCC-9810proliferation and the underlying molecular mechanism. Methods:The proliferation of HCCC-9810 treated with HGF was detected by MTT assay and EdU assay. The expression of Akt in HCCC-9810 cells was inhibited by siRNA. Western blot was used to detect the expression of cyclin D1 and the phosphorylation level of Akt. Results:Both 50 ng / ml and 100 ng / ml HGF significantly inhibited the proliferation of HCCC-9810. Western blotting assay showed that HGF downregulated the expression of cyclin D1 and the phosphorylation level of Akt in HCCC-9810 cells. Conclusion:These results suggest that HGF inhibited the proliferation of HCCC-9810 by suppressing the expression of cyclin D1 and the phosphorylation level of Akt. SiRNA interfered the expression of Akt,and blocked HGF-induced downregulation of cyclin D1 expression and inhibition of cell proliferation.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2014年第7期870-874,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省苏北人民医院院级科研基金项目(yzucms201318)
关键词 HGF 肝癌细胞 增殖 Akt CYCLIN D1 HGF liver carcinoma cell proliferation Akt Cyclin D1
  • 相关文献

参考文献19

  • 1Boros P,Miller CM.Hepatocyte growth factor-a multi-functional cytokine [ J ].Lancet,1995,345(8945):293-295.
  • 2Cecchi F,Rabe DC,Bottaro DP.Targeting the HGF/Met signaling pathway in cancer therapy [J].Expert Opin Ther Targets,2012,16(6):553-572.
  • 3Tang D,Nagano H,Nakamura M,et al.Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcino-ma:a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma[J].J Gastrointest Surg,2006,10(7):987-998.
  • 4Shaib Y,El-Serag HB.The epidemiology of cholangiocar-cinoma [ J ].Semin Liver Dis,2004,24(2):115-125.
  • 5Nakamura T,Nawa K,Ichihara A.Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats[J].Biochem Biophys Res Commun,1984,122(3):1450-1459.
  • 6Zarnegar R,Petersen B,Defrances MC,et al.Localization of hepatocyte growth factor(HGF)gene on human chro-mosome 7[J].Genomics,1992,12(1):147-150.
  • 7Bhargava M,Joseph A,Knesel J,et al.Scatter factor and hepatocyte growth factor:activities,properties,and mech-anism[J].Cell Growth Differ,1992,3(1):11-20.
  • 8Gherardi E,Birchmeier W,Birchmeier C,et al.Targeting MET in cancer:rationale and progress[J].Nat Rev Can-cer,2012,12(2):89-103.
  • 9Sheppard K,Kinross KM,Solomon B,et al.Targeting PI3 kinase/AKT/mTOR signaling in cancer [J].Crit Rev Oncog,2012,17(1):69-95.
  • 10Glaysher S,Bolton LM,Johnson P,et al.Targeting EGFR and PI3K pathways in ovarian cancer [J].Br J Cancer,2013,109(7):1786-1794.

同被引文献15

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部